First Patient Randomized in Phase 2 Trial to Assess Efficacy of NBI-1070770 for MDD - MD Magazine

Submitted by Anonymous (not verified) on Wed, 04/03/2024 - 15:04

First Patient Randomized in Phase 2 Trial to Assess Efficacy of NBI-1070770 for MDD  MD Magazine